The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Recruiting · NCT06548256 · Interventional (participants receive a specific treatment) · Lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Miyarisan-BM (Clostridium Butyricum Miyairi)
What this trial is about
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Who can take part
Age range
20 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male or female over 20 years old, diagnosed with Parkinson's disease.
Exclusion criteria
- People with Parkinson's disease Dementia, or Lactose Intolerance
Where it is running
1 location listed.
- Kaohsiung Medical Univeristy Hospital - Kaohsiung City, Taiwan